Tower Research Capital LLC (Trc) Synaptogenix, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.16 - $0.3 $45 - $85	-284 Reduced 73.58%	102 $0
Q4 2023 Feb 13, 2024	SELL	$0.23 - $0.4 $33 - $57	-144 Reduced 27.17%	386 $0
Q3 2023 Nov 14, 2023	SELL	$0.28 - $1.04 $6 - $24	-24 Reduced 4.33%	530 $0
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.0 $16 - $21	-21 Reduced 3.65%	554 $0
Q1 2023 May 09, 2023	BUY	$0.8 - $1.33 $460 - $764	575 New	575 $0
Q2 2022 Aug 15, 2022	BUY	$3.88 - $7.41 $2,525 - $4,823	651 Added 161.54%	1,054 $5,000
Q1 2022 May 12, 2022	SELL	$6.31 - $10.09 $2,214 - $3,541	-351 Reduced 46.55%	403 $3,000
Q4 2021 Feb 14, 2022	SELL	$8.38 - $13.72 $2,849 - $4,664	-340 Reduced 31.08%	754 $6,000
Q3 2021 Nov 15, 2021	BUY	$6.65 - $12.1 $7,275 - $13,237	1,094 New	1,094 $11,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $22.9M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.